Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

213 trials indexed
Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial New England Journal of Medicine

Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components

A large-scale trial found no significant difference in 30-day mortality between prehospital whole blood and component transfusions for trauma.

May 20, 2026 Read the trial →
Bispecific CAR T-Cells Show High Response in Extramedullary Multiple Myeloma Randomized Controlled Trial
Blood

Bispecific CAR T-Cells Show High Response in Extramedullary Multiple Myeloma

A phase 2 trial reports high overall response and manageable safety with anti-BCMA/GPRC5D CAR T-cells for relapsed/refractory disease.

May 24, 2026
Imdusiran Demonstrates Favorable Safety Profile in Early Hepatitis B Trial Randomized Controlled Trial
˜The œLancet. Gastroenterology & hepatology

Imdusiran Demonstrates Favorable Safety Profile in Early Hepatitis B Trial

A phase 1a/b study of the siRNA imdusiran shows it is well tolerated in healthy individuals and chronic hepatitis B patients.

May 23, 2026
CBD's Pain Modulation Effects Vary by Opioid Dosing Timing in OUD Patients Randomized Controlled Trial
Neuropsychopharmacology

CBD's Pain Modulation Effects Vary by Opioid Dosing Timing in OUD Patients

A crossover study reveals cannabidiol's impact on pain sensitivity is dependent on whether opioid agonist treatment has been administered.

May 23, 2026
ITBS Improves Fibromyalgia Symptoms; D-Cycloserine Augments Depressive Symptoms Only Randomized Controlled Trial
Neuropsychopharmacology

ITBS Improves Fibromyalgia Symptoms; D-Cycloserine Augments Depressive Symptoms Only

A randomized trial found intermittent theta-burst stimulation significantly reduced fibromyalgia symptoms, but adjunctive D-Cycloserine only…

May 23, 2026
GIP Infusion Does Not Improve Glycemic Control in Type 2 Diabetes Randomized Controlled Trial
Lancet Diabetes & Endocrinology

GIP Infusion Does Not Improve Glycemic Control in Type 2 Diabetes

A 6-week subcutaneous GIP infusion, alone or with semaglutide, did not meet its primary glycemic target in patients with type 2 diabetes.

May 23, 2026
Venetoclax Plus Chemotherapy Improves MRD Response, Survival in Ph-Negative ALL Non-Randomized Controlled Trial
Blood

Venetoclax Plus Chemotherapy Improves MRD Response, Survival in Ph-Negative ALL

A phase 2 study shows venetoclax combined with pediatric-inspired chemotherapy enhances outcomes for newly diagnosed adolescents and adults.

May 22, 2026
Cryoprobe Improves Diagnostic Yield in Transbronchial Lung Biopsy Randomized Controlled Trial
JAMA

Cryoprobe Improves Diagnostic Yield in Transbronchial Lung Biopsy

A multicenter randomized trial finds 1.1-mm cryoprobes provide higher diagnostic yield than 2.0-mm forceps for lung biopsies.

May 22, 2026
ABCDEF Bundle Does Not Reduce Delirium, Improves Specific Quality of Life Domain Randomized Controlled Trial
Critical Care Medicine

ABCDEF Bundle Does Not Reduce Delirium, Improves Specific Quality of Life Domain

A randomized trial in Australian ICU patients found no delirium reduction with the ABCDEF bundle, but noted better 90-day 'usual activities' scores.

May 21, 2026
AI 3D Morphing Reduces Revisions, Improves Outcomes in African American Rhinoplasty Non-Randomized Controlled Trial
Plastic & Reconstructive Surgery

AI 3D Morphing Reduces Revisions, Improves Outcomes in African American Rhinoplasty

A study of 392 patients found AI 3D morphing in rhinoplasty led to fewer revisions and better aesthetic and psychosocial scores.

May 21, 2026
Low-Dose Buprenorphine Sustains Ketamine's Antisuicidal Effects in MDD Randomized Controlled Trial
American Journal of Psychiatry

Low-Dose Buprenorphine Sustains Ketamine's Antisuicidal Effects in MDD

A randomized trial indicates sublingual buprenorphine extends ketamine's rapid reduction of suicidal ideation in major depressive disorder.

May 21, 2026
MIPD Improves Early Postoperative Activity, Reduces Stress for Pancreatic Resection Randomized Controlled Trial
JAMA Surgery

MIPD Improves Early Postoperative Activity, Reduces Stress for Pancreatic Resection

A randomized trial shows minimally invasive pancreatoduodenectomy leads to higher physical activity and heart rate variability for weeks.

May 21, 2026
IL-6 Inhibition Shows Clinical Signals in Refractory Depression Randomized Controlled Trial
JAMA Psychiatry

IL-6 Inhibition Shows Clinical Signals in Refractory Depression

A small trial of tocilizumab for difficult-to-treat depression suggests potential for symptom improvement and identifies patient selection markers.

May 21, 2026
Azithromycin Does Not Reduce Acute Wheezing Severity in Preschoolers Randomized Controlled Trial
New England Journal of Medicine

Azithromycin Does Not Reduce Acute Wheezing Severity in Preschoolers

A multicenter trial found azithromycin offered no significant clinical benefit over placebo for moderate-to-severe wheezing symptoms.

May 21, 2026
Weight Loss Intervention Safe in Older AF Patients, But Does Not Improve Symptoms Randomized Controlled Trial
JAMA

Weight Loss Intervention Safe in Older AF Patients, But Does Not Improve Symptoms

A randomized clinical trial indicates that while weight loss is achievable and safe in older, overweight AF patients, it may not reduce AF symptoms.

May 21, 2026
Inhaled Treprostinil Slows Lung Function Decline, Reduces Clinical Worsening in IPF Randomized Controlled Trial
New England Journal of Medicine

Inhaled Treprostinil Slows Lung Function Decline, Reduces Clinical Worsening in IPF

A phase 3 trial demonstrates that inhaled treprostinil significantly mitigates FVC reduction and clinical deterioration in patients with idiopathic.

May 20, 2026
4% Tetrasodium EDTA Lock Reduces CVAD Complications in ICU Adults Randomized Controlled Trial
JAMA

4% Tetrasodium EDTA Lock Reduces CVAD Complications in ICU Adults

A multicenter, cluster-randomized trial shows 4% t-EDTA locking fluid decreases a composite of CVAD-associated events, primarily catheter occlusions.

May 20, 2026
Tezepelumab Reduces Oral Corticosteroid Use in Severe Asthma Randomized Controlled Trial
Lancet Respiratory Medicine

Tezepelumab Reduces Oral Corticosteroid Use in Severe Asthma

A phase 3 trial demonstrates that tezepelumab significantly lowers daily oral corticosteroid dose in adults with severe, OCS-dependent asthma.

May 20, 2026
Amitriptyline Not Superior to Placebo for Leprosy-Related Neuropathic Pain Randomized Controlled Trial
Pain

Amitriptyline Not Superior to Placebo for Leprosy-Related Neuropathic Pain

A randomized controlled trial found amitriptyline did not offer additional analgesia as add-on therapy for neuropathic pain in leprosy.

May 20, 2026
Selective Early PDA Pharmacotherapy Feasible in Extremely Preterm Infants Randomized Controlled Trial
Archives of Disease in Childhood Fetal & Neonatal

Selective Early PDA Pharmacotherapy Feasible in Extremely Preterm Infants

A pilot randomized trial demonstrates the feasibility of a targeted medical approach for patent ductus arteriosus in infants under 26 weeks'.

May 20, 2026
New Tool Assesses Integrative Oncology Competencies in Trainees Randomized Controlled Trial
Journal of Pain and Symptom Management

New Tool Assesses Integrative Oncology Competencies in Trainees

A validated questionnaire helps evaluate baseline clinical skills in integrative oncology among healthcare provider trainees, supporting targeted.

May 20, 2026
Remote Multicomponent Rehabilitation Does Not Improve Quality of Life for ICU Survivors Randomized Controlled Trial
JAMA

Remote Multicomponent Rehabilitation Does Not Improve Quality of Life for ICU Survivors

A randomized trial found a 6-week remote rehabilitation program did not significantly enhance health-related quality of life at 8 weeks.

May 20, 2026
AD109 Reduces Apnea-Hypopnea Index in PAP-Intolerant OSA Patients Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine

AD109 Reduces Apnea-Hypopnea Index in PAP-Intolerant OSA Patients

An oral combination of aroxybutynin and atomoxetine significantly improved objective respiratory metrics over 26 weeks.

May 20, 2026
Astegolimab Reduces COPD Exacerbations in Broad Patient Population Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine

Astegolimab Reduces COPD Exacerbations in Broad Patient Population

A pooled analysis of two trials shows astegolimab significantly lowers moderate/severe exacerbation rates in patients with frequent COPD.

May 19, 2026
Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients Randomized Controlled Trial
Intensive care medicine

Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients

A randomized controlled trial found out-of-bed armchair positioning increased PaO2/FiO2 ratios compared to in-bed semi-recumbent positioning.

May 18, 2026
Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats Randomized Controlled Trial
Brain Research

Tea Polyphenols Mitigate Brain Changes, Anxiety in Aged Diabetic Rats

A preclinical study in aged T2DM rats suggests tea polyphenol intervention may improve hippocampal structure, function, and behavior.

May 18, 2026
Digital Decision Aid Boosts STI Testing in ED for Young Adults Randomized Controlled Trial
Annals of emergency medicine

Digital Decision Aid Boosts STI Testing in ED for Young Adults

A randomized trial shows a smartphone-based tool significantly increases gonorrhea/chlamydia and pharyngeal STI testing rates in emergency department

May 17, 2026
Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma Non-Randomized Controlled Trial
Neuropsychopharmacology

Sternal Vibration Plus Mindfulness Improves Body Awareness, White Matter in Trauma

A study in trauma-exposed adults found sternal vibration combined with mindfulness meditation enhanced interoceptive awareness and increased neurite.

May 17, 2026
Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS Randomized Controlled Trial
CHEST Journal

Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS

A phase 1b/2 trial indicates STSA-1002 is well tolerated and associated with lower 28-day mortality in viral pneumonia-induced ARDS.

May 17, 2026
CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months Randomized Controlled Trial
Biological Psychiatry

CTBS to Right DLPFC Reduces Heavy Drinking Relapse Risk in AUD Over 12 Months

Continuous theta-burst stimulation to the right DLPFC lowered heavy-drinking relapse risk in AUD over 12 months in a randomized trial.

May 17, 2026